Feasibility of Egg White Pudding Supplementation for Individuals in Personal Care Home Centres Needing Dietary Supplementation

September 1, 2026 updated by: Navdeep Tangri, Seven Oaks Hospital Chronic Disease Innovation Centre
This trial is an open-label randomized controlled parallel arm feasibility trial. 54 residents in care homes receiving nutrition supplementation (minimum 40% of each sex, ≥ 50 years of age). Participants will receive the egg white pudding (experimental) or a standard currently provided dietary supplement (control) on a daily basis and will be advised to follow any dietary recommendations they receive from their care team. Participants will be recruited at personal care homes throughout Winnipeg. Study visits will take place with a study coordinator at baseline and at 8 weeks (endpoint). Product acceptability will be assessed through dietary logs. This study has been reviewed and approved by The Committee for Harmonized Health Impact, Privacy, and Ethics Review (CHIPER).

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This trial is an open-label randomized controlled parallel arm feasibility trial. 54 residents from non-shared health personal care home centres (target of a minimum 40% of each sex, ≥ 50 years of age) will be recruited. Participants will receive the egg white pudding (experimental) 5 days a week or a standard currently provided dietary supplement (control) 7 days a week and will be advised to follow any dietary recommendations they receive from their care team. The personal care home team will approach residents or their ADM to participate in the research. Once a potential participant confirms interest, the research team will approach them for scheduling a screening visit. As part of the screening process, the care team may provide the research team with information on the participant's MDS (Minimum Data Set) level, which is routinely collected by personal care homes in Canada (levels 1-3). This information will be recorded at the screening visit for descriptive purposes only and will not be used to exclude any participants. The research coordinator and research assistant will also oversee and document the dispensing of products, which will be administered by the care team at the home care centre. After the screening visit, study visits will take place with a research coordinator or research assistant at Week 1 (baseline) and at Week 8 (endpoint). Product acceptability will be assessed through feedback questionnaire.

Study Type

Interventional

Enrollment (Estimated)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Canada
    • Manitoba
      • Winnipeg, Manitoba, Canada
        • Recruiting
        • The Saul and Claribel Simkin Centre
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Residing in a partnering Personal Care Home
  • Participant is willing and able to give informed consent for participation in the trial or has an ADM who is authorized to provide consent on their behalf.
  • Male or female aged ≥50 years

Exclusion Criteria:

  • Allergy to eggs
  • Inability to consume treatment product
  • Unable to provide written consent
  • Unable to understand English
  • Does not have an ADM

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control
Resource 2.0
Dietary supplement: Nestle Resource
Participants in the control group will be given 180 ml of Resource 2.0 seven days a week for 8 weeks.
Experimental: Experimental
Egg White Pudding
Dietary supplement: Egg White Pudding
Participants will be given a high protein egg white pudding 5 days a week for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hand Grip Strength
Time Frame: 8 weeks
Hand grip strength will be measured using a specialized handheld device called a hand dynamometer that records the maximum isometric force generated in kilograms or pounds.
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Waist circumference
Time Frame: 8 weeks
The study staff will wrap a flexible tape measure around participants' middle at the level of the belly button or just above the hip bones.
8 weeks
Body weight
Time Frame: 8 weeks
Body weight will be measured by participants stepping onto a digital or mechanical weighing scale placed on a hard, flat surface
8 weeks
Calf Circumference
Time Frame: 8 weeks
The study staff will wrap a flexible tape measure around the widest part of participants' lower leg while keeping the tape snug but comfortable.
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Seven Oaks Hospital Chronic Disease Innovation Centre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 8, 2026

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 1, 2027

Study Registration Dates

First Submitted

June 22, 2026

First Submitted That Met QC Criteria

September 1, 2026

First Posted (Actual)

September 8, 2026

Study Record Updates

Last Update Posted (Actual)

September 8, 2026

Last Update Submitted That Met QC Criteria

September 1, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HS26476

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe